Brand Awareness Archives - BioMedWire (BMW)

ThursdayJul 15, 2021 1:08 pm

Report Finds That Use of Remote Health Has Grown Significantly

A recent survey conducted in the second quarter of this year by Parks Associates has found that more than one-half of broadband households own an internet-enabled fitness or health device that records biometric data, with another two-thirds revealing that they have undergone remote health consultation. The survey, which involved 5,000 broadband households in the United States was conducted by Parks Associates, a market research and consulting firm that specializes in emerging consumer technology products. Parks Associates senior analyst Kristen Hanich stated that the overall familiarity with telehealth had assisted in driving the connected health device market. Hanich noted that there…

TuesdayJun 22, 2021 3:00 pm

Customized Brain Maps Help Boost Cancer, Epilepsy Treatments Outcomes

A team of medical device developers, neuroscientists, surgeons and engineers from the University of California San Diego is working on developing better customized maps that will be useful to physicians during brain tumor removal surgery. Maps do already exist that physicians can reference. However, one individual’s brain isn’t the same as another’s, which is why customized maps are needed. Additionally, an individual’s brain may sometimes reorganize itself as a response to damage caused by things such as growing tumors, which can make it even harder to remove the tumor. This is where sensors enter the picture. Surgical teams can utilize…

FridayJun 18, 2021 2:14 pm

How What You Eat Affects Your Brain Health

A recently released study discovered that individuals who routinely consumed processed meat along with sugary drinks and snacks that were high in sodium tended to have smaller left hippocampi, which is the part of the brain that is responsible for mental health, learning and memory. The study, which was conducted by researchers from the Australian National University and Deakin University, also found that older individuals who consumed healthier diets had larger hippocampi. The researchers concluded that a higher intake of unhealthy food and a lower intake of nutrient-dense foods were each independently linked to a smaller hippocampus volume, noting that…

FridayMay 28, 2021 10:00 am

UM Twin Cities Researchers Find Way to Optimize Immune Response Against Cancer

In what many have described as groundbreaking work, a team of researchers based at University of Minnesota Twin Cities has demonstrated how the body’s immune cells can be engineered in order to navigate the physical barriers that make it hard for an individual’s immune system to fight cancerous tumors. This study has the potential to improve how millions of cancer patients are treated. The research paper was published in the journal “Nature Communications.” Conventionally, cancers are commonly treated through the use of chemicals (chemotherapy), radiation and surgery. Combinations of these approaches are also common. However, immunotherapy is also gaining ground…

TuesdaySep 24, 2019 9:00 am

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers

BioMedWire Editorial Coverage: Advances in biotechnology look to deliver promising new treatment options against breast cancer. Independent researchers have found that Genprex Inc.’s (NASDAQ: GNPX) (GNPX Profile) TUSC2 prevented tumor growth against triple-negative breast cancer. Eli Lilly and Company (NYSE: LLY) is focusing on those patients with the greatest need and, in the process, has developed a new breast-cancer treatment option. Roche Holding (OTCQX: RHHBY) is expanding the use of its biotech to both identify and treat patients with challenging breast cancers. AbbVie Inc. (NYSE: ABBV) has been rapidly increasing its research, targeting more than 15 different types of cancer.…

WednesdaySep 04, 2019 9:00 am

Gene Therapy Treatments Offer Hope for Cancer Patients

BioMedWire Editorial Coverage: Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different…

WednesdayAug 21, 2019 9:00 am

Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector

BioMedWire Editorial Coverage: Biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on investment. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) has completed key steps in its overall strategy to expand its clinical development programs and bring Oncoprex(TM) immunogene therapy, its lead drug candidate, to commercialization. Over the past five years, Amgen Inc. (NASDAQ: AMGN) has invested nearly $19 billion in R&D and, as a result, is now advancing a record number of clinical assets. Biogen Inc. (NASDAQ: BIIB) has added four new programs…

WednesdayMay 29, 2019 9:00 am

Biotechs That Successfully Combat Cancer Could See Blockbuster Returns

BioMedWire Editorial Coverage: Gene therapy is hot on the trail of killing cancer, and companies that deliver cures could see blockbuster returns. Pioneering a new paradigm in cancer therapeutics, Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is leveraging its patented technology platform to deliver powerful tumor-suppressing genes directly into cancer cells. Calithera Biosciences Inc. (NASDAQ: CALA) is looking for cures for cancer and other life-threatening diseases by discovering, developing and commercializing novel, small-molecule drugs that target tumor and immune cell metabolism. Adaptimmune Therapeutics plc (NASDAQ: ADAP) is developing novel cancer immunotherapy products for cancer patients by engineering T-cells to target and destroy cancer. Agenus…

TuesdayMay 07, 2019 9:00 am

New Gene Therapies Hold Out Promise for Patients

BioMedWire Editorial Coverage: Gene therapies are gaining growing attention within the medical sector. Gene therapies help restore or replace the body’s damaged or missing genes. Groundbreaking treatments can stop the spread of cancer cells, cause cancer cells to die. Gene therapies are also being developed for ailments such as migraines, skin conditions and hemophilia. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is developing gene therapies for the treatment of cancer, including its initial drug candidate, Oncoprex(TM) immunogene therapy. Spark Therapeutics Inc. (NASDAQ: ONCE) is tackling hereditary diseases through treatments that augment, suppress or replace mutated genes. Dyadic International Inc. (OTCQX: DYAI)…

WednesdayApr 10, 2019 9:00 am

Potential Blockbuster Gene Therapy Programs to Watch in 2019

BioMedWire Editorial Coverage: Several revolutionary gene therapies appear to be on the verge of delivering remarkable remedies for diseases that have previously been viewed as untreatable. Gene therapy is the next great leap forward in medicine, with several noteworthy programs underway looking to cure the incurable FDA expects 200 new gene and cell therapy INDs in next two years Genprex — and its initial product candidate Oncoprex — is pioneering a new approach to treating cancer. Built on decades of scientific research and innovation, gene therapy is the next frontier of medicine, determined to provide remedies for previously untreatable diseases…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Category: Brand Awareness

Report Finds That Use of Remote Health Has Grown Significantly

Customized Brain Maps Help Boost Cancer, Epilepsy Treatments Outcomes

How What You Eat Affects Your Brain Health

UM Twin Cities Researchers Find Way to Optimize Immune Response Against Cancer

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers

Gene Therapy Treatments Offer Hope for Cancer Patients

Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector

Biotechs That Successfully Combat Cancer Could See Blockbuster Returns

New Gene Therapies Hold Out Promise for Patients

Potential Blockbuster Gene Therapy Programs to Watch in 2019

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search